Should we accept a higher cost per health improvement for orphan drugs? A review and analysis of egalitarian arguments

Title
Should we accept a higher cost per health improvement for orphan drugs? A review and analysis of egalitarian arguments
Authors
Keywords
-
Journal
BIOETHICS
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2020-07-20
DOI
10.1111/bioe.12786

Ask authors/readers for more resources

Find the ideal target journal for your manuscript

Explore over 38,000 international journals covering a vast array of academic fields.

Search

Become a Peeref-certified reviewer

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started